Adaptyv Bio

Lausanne protein-design validation lab-as-a-service — runs open binder-design competitions and experimentally validates AI-designed proteins.

1. Core Product / Service

Adaptyv Bio (Adaptyv Biosystems) runs an automated protein-validation wet lab in Lausanne: customers submit protein designs as digital sequences via web platform or API, and Adaptyv synthesizes the DNA, expresses proteins cell-free, and measures binding (e.g. via SPR), returning experimental data [1]. The company is the experimental counterpart to computational protein design — it closes the loop between AI-generated designs and physical validation.

Its second product is open protein-design competitions, published on the Proteinbase hub (launched Oct 6, 2025), where designs are experimentally validated in Adaptyv's lab and results are released publicly [2]. Reported runs: EGFR binder competitions (201 designs / 2.5% hit rate → 400 designs / 14% hit rate, best 1.21 nM), a Nipah binder competition (1,200 tested, best 0.37 nM), and a May 2026 TREM2 hackathon where human teams (38.5% hit rate) beat autonomous LLM agents (34.3%) [2]. An Anthropic × Adaptyv Protein Design Competition (Sep–Dec 2026, five challenges, 5,000+ designs) is the headline 2026 partnership [2].

2. Target Users & Pain Points

• AI protein-design teams (academic and startup) that can generate candidate binders but cannot wet-lab validate them — Adaptyv is the validation layer.
• Pharma / biotech evaluating whether computationally designed binders are real before committing to a program.

Pain solved: the wet-lab validation step is the bottleneck of the design loop. Adaptyv turns "does my AI-designed protein actually bind?" into an API call, making validation a commodity rather than an in-house capital expense. Jimmy's 2026-09-29 notes put Adaptyv's automated-lab equipment investment at roughly $2–5M (Thermo Fisher / PerkinElmer as main vendors) [1].

3. Competitive Landscape

Adaptyv differentiates through the open, public benchmark format — the competitions themselves became an industry reference because results are openly comparable [1][2].

4. Unique Observations

• Open competitions became the industry benchmark. Adaptyv's public, experimentally-scored binder challenges (hit rates, affinities published) turned an automated lab into a neutral evaluation ground — the protein-design equivalent of a benchmark leaderboard. That is the main reason third parties (Anthropic, EPFL, GEM) run their evaluations through it [1][2].
• The "verification" middle layer. Between AI design (alphafold3, RFdiffusion-style tools, david-baker's lab) and manufacturing, Adaptyv occupies a niche that's neither compute nor drug development — a pure measurement utility. Jimmy frames it as part of the broader "验证-预测-优化" (verify–predict–optimize) closed loop that wet-lab automation unlocks [1].
• Human vs agent gap is measurable. The TREM2 hackathon result (humans 38.5% vs autonomous agents 34.3%) is an early, concrete data point on how far autonomous protein-design agents still trail expert humans [2].

5. Financials / Funding

• YC S21 (Y Combinator) [3].
• CHF 2.5M from Swiss VC Wingman Ventures (pre-seed) [3].
• $8M Seed (Nov 2024), led by ACE Ventures, with byFounders and Y Combinator [2].
• $40M Series A, led by Highland Europe, with ACE Ventures doubling down plus byFounders and Y Combinator — to triple lab capacity by end-2026, open a London lab/office in Q4 2026, and grow the team from ~25 to ~60 [2].
• CB Insights lists ~$11.17M raised as of an earlier Seed VC-III round (predates the $40M Series A) [4].

6. People & Relationships

• CEO / co-founder: Julian Englert.
• CTO / co-founder: Daniel Nakhaee-Zadeh Gutierrez.
• Co-founders: Moustafa Houmani, Amir Shahein.
• Origin: EPFL-affiliated team, Lausanne; co-organizes the EPFL Protein Design Week Myostatin binder challenge [2][3].
• Partners: Anthropic (2026 competition), EPFL, GEM (RBX1 competition), muni (TREM2 hackathon) [2].
• Competitors / adjacent: Twist Bioscience, Ginkgo Bioworks, generate-biomedicines, evolutionary-scale, lila-sciences.

Sources

[1] local: 2026-09-28/29-summary.md — Adaptyv vs Twist comparison; why the open competition became an industry benchmark; binder challenge mechanics; automated-lab equipment (~$2–5M); Anthropic collaboration. [2] WOWTALE, "Adaptyv Bio Raises $40M to Automate the Lab That Validates AI-Designed Proteins," https://en.wowtale.net/2026/08/29/234934/ (2026-10-05); Proteinbase, "EPFL Protein Design Week x Adaptyv," https://proteinbase.com/competitions/epfl-adaptyv-myostatin (2026-10-05) [3] EPFL News, "Adaptyv Biosystems secures funding from Y Combinator," https://news.epfl.ch/news/adaptyv-biosystems-secures-funding-from-y-combinat/ (2026-10-05) [4] CB Insights, "Adaptyv Biosystems," https://www.cbinsights.com/company/adaptyv-biosystems (2026-10-05)